All In MedTech

FDA Clearance Tracker · P920015-S234

MEDTRONIC(R) TRANSVENE LEAD SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 23, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 23, 2020

Approved

Time to decision

297 days

Received Jul 1, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P920015-S234
Device name
MEDTRONIC(R) TRANSVENE LEAD SYSTEM
Applicant location
Mounds View, MN
Received
Jul 1, 2019
Decided
Apr 23, 2020
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P920015

Device type

Device class
Class III

Every decision under product code NVY

FDA's approval statement

As written in FDA's record.

Approval for Cobalt XT, Cobalt, and Crome MRI SureScan Implantable Cardioverter Defibrillator (ICD) and ICD with Cardiac Resynchronization Systems.

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.